New pathogenic and therapeutic concepts in systemic sclerosis
Thomas Hügle1, Christiaan A Huigens, Jacob M van Laar
1Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom. T.Huegle@ncl.ac.uk
Arzneimittel-Forschung
|January 30, 2010
Summary
Systemic sclerosis (SSc) research advances understanding of its complex pathogenesis. New targeted therapies and stem cell transplantation offer hope for treating this autoimmune disease.
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive fibrosis and vasculopathy.
- The disease's complexity and heterogeneity have historically hindered research.
- Recent advancements in research tools and models have improved understanding of SSc pathogenesis.
Purpose of the Study:
- To review the translation of pathogenic findings in SSc into therapeutic strategies.
- To provide an overview of current and emerging treatments for SSc.
Main Methods:
- Review of recent research findings in SSc.
- Analysis of advancements in genomics, cytokine expression, autoantibodies, and cell abnormalities.
- Evaluation of therapeutic compounds and stem cell transplantation.
Main Results:
- New insights into SSc pathogenesis derived from genomics, cytokine profiles, autoantibodies, and cellular abnormalities.
- Clinical investigation of targeted therapies like imatinib.
- Autologous stem cell transplantation as a potential multitarget approach.
Conclusions:
- Progress in understanding SSc pathogenesis is paving the way for novel therapeutic interventions.
- Targeted therapies and stem cell transplantation represent promising avenues for SSc treatment.
- Continued research is crucial for developing effective strategies against SSc.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...